This web page presents the Prosthetic and Orthotic Policy Manual in its entirety. You can find what you need using the table of contents below, or use CTRL+F to search for keywords.
2 Prosthetic and Orthotic Program Overview
7 Applying for Pre-Approval and Submitting Claims
This manual explains the mandate and scope of the PharmaCare Prosthetic and Orthotic (P&O) Program, and provides the information required to request pre-approval for prosthetic and orthotic devices and services, and to submit claims to PharmaCare, for all benefits under the PharmaCare P&O Program.
[Recent updates: Section 2.4.2 and Section 5.8]
The manual includes both program policies and procedures.
This manual should be read in conjunction with the PharmaCare Policy Manual, which describes the different PharmaCare plans and details PharmaCare’s overarching policies and procedures, including those on enrolling as a provider, connecting to PharmaNet, and audit procedures.
This manual supplements the general policies set forth in the PharmaCare Policy Manual.
For purposes of this manual, the following definitions apply:
Activities of daily living (ADL): Activities of daily living are the skills required to manage one’s basic physical needs (e.g., transferring or ambulating, personal hygiene or grooming, dressing, eating, and toileting).
Application: Application for Financial Assistance forms; there are separate forms for prosthetic benefits, prosthetic benefits (non-limb), and orthotic benefits.
Basic function: Clients are assessed to determine what they need to perform basic activities of daily living (ADL). Basic ADL varies between clients. Assessment is based on factors such as a client’s age, health and activity level. Refer to Section 5.1.1 for more information.
Client: An individual requiring a basic function device such as a prosthesis, orthosis, or an eligible supply.
Cover/coverage: A client is “covered” if they qualify for one or more PharmaCare plans; an item is “covered” if it is eligible for any level of reimbursement by PharmaCare. “Coverage” differs from “reimbursement” in that “coverage” indicates general eligibility, whereas “reimbursement” applies to a PharmaCare payment for an item.
Device: In this document, a device refers to a prosthesis (such as a leg, arm, eye or breast), an orthosis or an eligible supply (such as liners or lymphedema arm sleeves).
Eligible client: A client may be eligible for prosthetic and orthotic benefits if they are covered under PharmaCare plans I (Fair PharmaCare), B, C or F. See Section 4.1 for details on client eligibility and exclusions.
Financial control: Is an entry in PharmaNet, made by PharmaCare, that allows a claim to be submitted and processed when an application is approved. This control expires six months after the approval is received, or the date that a claim is made. The date of expiry is shown in the “Approval Ends” field of an approved application form.
Health authority outpatient/ambulatory clinic: A site operated by a health authority in B.C. that provides outpatient services, including wound care (e.g., medical ambulatory outpatient clinic, medical day care centre, etc.). See B.C. Outpatient/Ambulatory Clinics Total Contact Casting (PDF, 83KB) for a list of approved health authority outpatient/ambulatory clinics providing total contact casting.
Health Insurance BC (HIBC): Health Insurance BC (HIBC) manages the day-to-day operations of PharmaCare, including adjudicating claims and providing information and support to the public and device providers.
Non-benefits: Devices, supplies and/or services that are not eligible for PharmaCare coverage.
Offloading device: A device (e.g., cast, walker, orthotic insert, or therapeutic footwear, etc.) used in wound care to offload pressure from an ulcer site to promote healing and/or prevent a recurrent ulcer.
Orthotic benefits: Includes orthoses and/or orthotic services that are eligible for PharmaCare coverage. Orthotic supplies are not eligible for PharmaCare coverage.
Orthotic cover: The point of contact between the orthotic insert and the patient. Covers function as a soft-tissue supplement for cushioning and to provide extra padding and shock absorption.
Osseointegration: Is defined as the direct structural and functional connection between the living bone and surface of a load-bearing implant
PharmaNet: PharmaNet is the secure province-wide computer network that links British Columbia’s community and hospital pharmacies, hospitals, online device providers, alternate payees and other authorized users to a central set of data systems.
Pre-approval: The process of obtaining PharmaCare approval for a prosthetic or orthotic device or service. Device providers submit descriptions of and cost estimates for the proposed components and service(s) to PharmaCare. PharmaCare then reviews the application and determines eligibility for coverage. See also coverage and reimbursement.
Product Identification Number (PIN): PharmaCare assigns a Product Identification Number (PIN) to identify a specific product or service. The PIN is submitted with the corresponding claim to allow proper adjudication of the claim in PharmaNet.
P&O: Abbreviation for “Prosthetic and Orthotic”
Prosthetic and Orthotic Committee (P&O Committee): The P&O Committee is responsible for ensuring consistency and accuracy in applying PharmaCare policy to prosthetic and orthotic applications’ adjudication.
Prosthetic benefits: Includes prostheses, and prosthetic supplies and/or services that are eligible for PharmaCare coverage.
Providers: Includes prosthetists, orthotists, ocularists, anaplastologists, mastectomy fitters and/or their companies or businesses (including pharmacies) who have enrolled with PharmaCare in the appropriate class(es) and subclass(es) for the product(s) they are dispensing.
Reimbursement: The portion of a claim that PharmaCare pays. Actual reimbursement may be less than the approved maximum amount, depending on the rules of the client’s PharmaCare plan. For instance, under Fair PharmaCare, the client is responsible for all or part of the eligible costs each year until both their family deductible and maximum family co-payments have been met.
Site ID: The unique identification code issued to a site by HIBC (e.g., BC00000A01). The site ID is provided when applying to enrol as a PharmaCare provider.
The Prosthetic and Orthotic (P&O) Program helps clients to achieve or maintain basic activities of daily living (ADL).
PharmaCare helps eligible clients pay for the cost of eligible prosthetic and orthotic benefits, subject to the rules of their PharmaCare plan, including any annual deductible requirements.
On behalf of their clients, providers must request PharmaCare pre-approval for all eligible devices, and supplies and services of $400 or more. PharmaCare approval must be received before the work on a device is started, a service is provided, or supplies are dispensed. Retroactive coverage is not available.
To obtain pre-approval, the appropriate application must be properly completed and submitted. The P&O Committee reviews each application and approves or denies the application, or asks for more information.
PharmaCare approval is valid for six months. If a benefit cannot be dispensed within six months, a new application must be submitted. The new application must include the reason why the item was not dispensed within the initial six month approval period and should note any changes (or no change) in the client’s health in the revised rationale. A new request may or may not be approved.
A claim may only be submitted to PharmaCare after the final dispense of an approved item, supply, or completed service. PharmaCare processes the claim and reimburses either the provider or the client, as appropriate. Actual reimbursement depends on the rules of the client’s PharmaCare plan. For instance, some plans reimburse 100% of the eligible claim whereas reimbursement under the Fair PharmaCare plan depends on how much of the client’s family deductible and maximum family co-payment have been met.
Health Insurance BC (HIBC) administers the PharmaCare program on behalf of the Pharmaceutical, Laboratory and Blood Services Division, Ministry of Health.
HIBC’s P&O Clerk is responsible for processing applications for pre-approval.
HIBC’s Help Desk staff are responsible for processing manual claims.
The P&O Program covers:
Refer to the reimbursement schedules and PINs documents for a list of items covered and maximum reimbursement amounts for each.
Not all prosthetic and orthotic devices and supplies are covered. For example, the following are not eligible for coverage:
Note: The above list is not a comprehensive list of non-benefits.
Most prosthetic/orthotic devices (even if under $400), and supplies, services, repairs, or adjustments of $400 or more require PharmaCare pre-approval.
To be eligible for reimbursement, applications for devices/services that require pre-approval must be submitted and approved before work on a device is started, a service is provided, or a supply is dispensed.
PharmaCare cannot pay for devices/services that are dispensed before PharmaCare approval is received.
If you are unsure whether a device requires pre-approval, contact the P&O Clerk for clarification.
[Updated July 16, 2024]
For policies and procedures for items that do not require pre-approval, please see Section 7.7.
The following items are covered without pre-approval:
*If additional items are deemed necessary for work related to an already pre-approved application, a new application for the entire request is required. Additionally, multiple claims may not be made over a short period of time for different portions of the cost. The $400 limit applies to all items, services, and supplies with the same date of dispense that are required for an individual client.
Providers must enrol with PharmaCare as a Device Provider in order to be reimbursed for products, services and supplies dispensed, and for their clients to be able to submit prosthetic and orthotic benefits claims.
For details on how to enrol, see the PharmaCare Provider Enrolment Guide and enrolment forms on the Medical Device Providers web page.
Device providers must also enrol in the appropriate device provider sub-class(es) and confirm that each person providing benefits is recognized by the appropriate board/manufacturer, as shown below.
If you are in enrolled in this sub-class… |
Benefits can be provided only by an individual… |
---|---|
compression garment |
who has completed training, by a compression garment manufacturer, in fitting the type of compression garments to be provided |
limb prosthesis |
recognized by the Orthotics Prosthetics Canada (OPC) as a person qualified to fit limb prostheses** |
breast prosthesis |
who has completed training, by a breast prosthesis manufacturer, in fitting breast prostheses |
ocular prosthesis |
recognized by the National Examining Board of Ocularists, Inc. as a person qualified to fit ocular prostheses |
orthosis |
recognized by the Orthotics Prosthetics Canada (OPC) as a person qualified to fit orthoses** |
**With regards to prosthetic or orthotic residents working in enrolled device clinics, residents must be registered with Orthotics Prosthetics Canada (OPC) and there must be a supervising certifee physically present and available to the resident at all times when the resident is working with PharmaCare patients.
Providers must abide by the PharmaCare policies and procedures set forth in:
Changes to provider information must be reported ahead of time to HIBC (e.g., change in contact information, change in manager, etc.). Failure to report these changes may result in delay or suspension of payments. See PharmaCare Provider Enrolment — Section 2.1, PharmaCare Policy Manual for notification requirements.
Updates are announced in the PharmaCare Newsletters. Anyone can subscribe to be automatically notified when a newsletter is published online.
Changes to, or clarifications of, PharmaCare policy and procedures are included as updates in this manual and/or the PharmaCare Policy Manual; updates are flagged with a notation that includes the nature of the update (policy change or policy clarification) and the effective date of the change.
Individuals are eligible for prosthetic benefits if they are covered under one or more of the following plans:
>> See the Fair PharmaCare — Section 7.2, PharmaCare Policy Manual, for more information on Fair PharmaCare or Plans Overview — Section 7.1, PharmaCare Policy Manual for other PharmaCare plans.
Individuals are not eligible for PharmaCare coverage if:
>> See the Patients: Other Payers — Section 3.4, PharmaCare Policy Manual, for details.
>> See the Patients: Other Payers — Section 3.4, PharmaCare Policy Manual, for details.
Exceptions may apply.
>> See the Patients: Other Payers — Section 3.4, PharmaCare Policy Manual, for details.
1The First Nations Health Benefits Program provides prosthetic and orthotic benefits to eligible beneficiaries. The application is made directly to Pacific Blue Cross.
Individuals are eligible for general orthotic benefits if they are 18 years old or younger and are covered under one or more of the following plans:
>> See Fair PharmaCare — Section 7.2, PharmaCare Policy Manual for more information about Fair PharmaCare or Plans Overview — Section 7.1, PharmaCare Policy Manual for other PharmaCare plans.
Individuals of any age are eligible for offloading orthotic benefits if they have a healed or nearly healed diabetic foot ulcer, are referred by a health authority outpatient/ambulatory clinic, and are covered under one or more of the following plans:
>> See Orthotics Referral: Post Completion of Total Contact Casting (PDF, 1MB) for an example of the health authority outpatient/ambulatory clinic referral form for offloading orthotics.
Individuals are not eligible for PharmaCare coverage if:
>> See Patients: Other Payers — Section 3.4, PharmaCare Policy Manual, for details.
>>See the Patients: Other Payers — Section 3.4, PharmaCare Policy Manual, for details.
Exceptions may apply.
>> See the Patients: Other Payers — Section 3.4, PharmaCare Policy Manual, for details.
Note: Other government programs may aid with purchasing orthoses that PharmaCare does not cover. In particular, Plan C clients or their agents should contact the Ministry of Social Development and Poverty Reduction, and Plan F clients or their agents should contact the Ministry of Children and Family Development to ask about available assistance.
2The First Nations Health Benefits Program provides prosthetic and orthotic benefits to eligible beneficiaries. The application is made directly to Pacific Blue Cross.
Families who are eligible for Fair PharmaCare, but who have not registered with the plan, are assigned a default annual deductible/family maximum of $10,000 per individual.
Families who have registered for Fair PharmaCare, but have not consented to income verification, or for whom income verification was not possible due to unfiled tax returns, are assigned a default annual deductible/family maximum of $10,000 per family.
Non-registered individuals who are not covered under another PharmaCare plan pay the full cost of eligible prescription drugs and designated medical supplies, including prosthetic or orthotic benefits, until they reach the $10,000 maximum per person. Once this maximum is reached, PharmaCare pays 100 per cent of eligible benefits.
Tip: Encouraging families to register for Fair PharmaCare
All families are encouraged to register for Fair PharmaCare even if they are covered by another PharmaCare plan. Doing so ensures that if coverage through their other plan(s) ends, Fair PharmaCare coverage will begin automatically.
To receive the maximum allowable coverage, families have to register for Fair PharmaCare before the benefit is dispensed to the client. Fair PharmaCare does not cover retroactive claims.
>> See the Fair PharmaCare — Section 7.2, PharmaCare Policy Manual, for more information about the Fair PharmaCare Plan and how to register.
A client’s eligibility for prosthetic and orthotic benefit coverage ends the day they leave the province to establish permanent residence elsewhere.
Important: Clients are required to report any address change to HIBC within 10 days of the change.
A client’s eligibility for orthotic benefits coverage ends the day they turn 19.
All prosthetic and orthotic benefits are subject to the policies detailed in this section, as applicable.
Any request for exceptions to these policies must be supported by sufficient justification and documentation to explain the need for an enhanced and/or more costly item. While PharmaCare considers exceptions, approval may not be granted even if justification is provided.
Important: PharmaCare does not fund travel, time for home and/or hospital visits or time providing assessments and/or consultations, including office visits.
The following section describes PharmaCare policies and procedures that apply to all prosthetic and orthotic benefits, regardless of type.
Providers are required to keep client notes detailing interactions with clients, services provided, items dispensed including final dispenses, and all corresponding dates. PharmaCare may request this information at any time for auditing purposes.
PharmaCare limits the benefits covered under the P&O Program to basic function devices and supplies needed to help clients achieve, regain, or maintain basic activities of daily living (ADL).
The basic levels of ADL vary from client to client. To determine whether a client needs a benefit device to achieve or regain levels of ADL (and what that level is), PharmaCare considers the:
If an application is approved, PharmaCare covers up to the allowable maximum for an appropriate basic function device.
PharmaCare usually covers the lowest-cost device available (with new or the patient’s own components) that meets the client’s needs to perform basic activities of daily living (ADL). When the same or similar component is offered at different prices by two or more suppliers, PharmaCare will cover the cost of the lowest-priced component. Device providers are required to register components with the patient’s name to allow for warranty claims.
If a high-activity component has been requested, PharmaCare will also consider the component’s warranty.
Clients may request an enhanced component (i.e., a higher-cost device that goes beyond what is needed to support the client in performing basic ADL but must understand that
The amount that PharmaCare reimburses may be less than the allowable maximum, depending on the client’s plan and annual deductible requirements.
The client is responsible for paying all costs not covered by PharmaCare.
PharmaCare covers only one prosthesis or orthosis per limb, per client.
PharmaCare covers only one plagiocephaly helmet.
Eligible exceptions are:
Specialty devices, such as swim or shower legs, are not covered.
Under certain circumstances, PharmaCare considers coverage for prostheses or orthoses only after receiving a written recommendation from a multi-disciplinary team.
The multi-disciplinary team must consist of two or more health care professionals, which may include:
A recommendation from a multi-disciplinary team is required if any of the following apply:
PharmaCare covers prostheses intended to achieve, regain, or maintain basic activities of daily living (ADL).
All “initial” and “upgrade” applications must include a prescription from a physician who is knowledgeable about prostheses.
Note: More complex cases may require a prescription from a multi-disciplinary team or specialist physician. See Section 5.1.4 for details.
The term “initial” includes the first request for:
Use the HLTH 5402 - Prosthetic Benefits: Application For Financial Assistance (PDF, 690KB) form for all pre-approval requests:
A pre-approval application for a prosthesis should include all components/services the client needs (i.e., adjustment costs, supplies, etc.), based on an assessment of the client and their current components by the responsible prosthetist.
An application for pre-approval must provide enough information to allow PharmaCare to make an informed decision.
This information must be included in the “Detailed Rationale for Request” section of the application form, and in the details about the device (“Schedule C” or a work order), as appropriate.
Reminder: Cost-splitting prohibition
Providers must not split the cost of supplies, components and/or services (i.e., adjustments and repairs) for across two or more claims to avoid having to obtain pre-approval.
Once pre-approval is received, providers cannot add additional components, supplies, or fees as a separate claim under $400. Any changes resulting in an increased claim amount must be resubmitted on a new application for PharmaCare’s pre‐approval before the item(s) is dispensed and a claim submitted.
Upgraded components provide a higher degree of mobility but still meet PharmaCare’s basic function requirements – for example, adding ankle-foot orthosis components to a partial foot-prosthesis.
This includes claims that are made for a single component or for a full prosthesis that is being upgraded to meet the changing needs of the client.
When are upgraded components covered?
PharmaCare will cover the cost of upgraded components for a client if
The application for pre-approval for a component upgrade must provide enough information to allow PharmaCare to make an informed decision. It must include:
Submit applications for pre-approval of an upgraded component on the HLTH 5402 - Prosthetic Benefits: Application for Financial Assistance (PDF, 690KB) form. Ensure “Upgrade” is checked in the “Service Information” section. All upgrades require a prescription.
Osseointegration benefits are available to trans-femoral and transtibial amputees who have undergone osseointegration implant surgery
Benefits are limited to those outlined on the osseointegration component list and include all clinical labour costs incurred in dispensing the approved items, including the following:
Prosthetic claims related to the manufacture and dispensing of a definitive socket are reimbursed based on the type and/or level of socket being fitted.
The maximum reimbursement amount for a definitive laminated socket includes all clinical labour costs and materials incurred in its creation and dispensing, including all of the following:
If a provider has a clinic-owned foot or knee that is being trialed by a client, PharmaCare will pay a fee to that provider for the maintenance of the loaned component. PharmaCare does not pay a maintenance loaner fee for a component that is on loan from the manufacturer.
PharmaCare covers a cosmesis for new amputees once stump volume has stabilized, when a new socket or prosthesis is requested, or when an existing cosmesis is damaged and needs replacing.
Submit applications for pre-approval of a cosmesis on the HLTH 5402 - Prosthetic Benefits: Application for Financial Assistance (PDF, 690KB) form. If you are only requesting a cosmesis, ensure “Cosmesis” is checked in the “Service Information” section.
Cosmesis—new amputee
PharmaCare covers the cost of a prosthetic limb cosmesis only after a new amputee’s stump volume has had time to stabilize.
Do not include the cosmesis on the application for the initial prosthesis. Once a new amputee’s stump volume stabilizes, submit a separate application for the cosmesis if all stabilization work, modifications, and component replacements during the adjustment period have been completed and the rationale identifies that the client is stable in the current socket.
Otherwise, make the request with a subsequent replacement prosthesis application.
Cosmesis—amputee requiring a replacement socket or prosthesis
If a replacement socket or prosthesis is being contemplated, request a cosmesis on the same application as the new socket or prosthesis. Do not use a separate application for the cosmesis.
Prosthetic limb supplies include items required for proper functioning of the prosthesis (e.g., socks, pins, locks, liners, etc.).
>> See below for details regarding claims for liners.
PharmaCare does not cover personal hygiene items such as lotions, antiperspirants and/or cleansers. Please do not submit claims for these items.
Depending on the type of liner requested, providers may need to include additional information about the liner as part of the application. Refer to the table below for details.
Category | Product | Pre-appoval and documentation requirements |
---|---|---|
Basic function liners |
|
Note: Even these basic liners require justification for approval. Some liners require additional justification as to why they are needed by the client (e.g., why does the client require a 9 mm liner rather than the standard 6 mm). |
Liners that exceed the basic function guidelines |
|
Provide appropriate written justification for the product. Documentation can include, but is not limited to:
Note 1: Although silicone liners are not considered basic function supplies some silicone liners are comparably priced to basic liners and are the liner of choice for some prosthetists. Therefore, PharmaCare may approve applications that include a liner with the same price or a lower price than a basic liner, without requiring additional clinical justification. However, the liner price may increase by the time it requires replacement. If so, the client would be responsible for any additional cost. It is therefore important that the client understand and agree to this before the original liner is requested. Note 2: A client who has been granted an exception from basic function liners may be eligible for ongoing approval of this exception for future requests for a silicone liner. Exceptions may end at any time without prior notice. |
PharmaCare does not cover prostheses for missing toes.
A partial foot prosthesis (including a hybrid partial foot prosthesis/ankle-foot orthosis) must be ankle height and must be for at least a transmetatarsal amputation. Types of prostheses covered include transmetatarsal and transtarsal (i.e., Chopart, Lisfranc).
PharmaCare will cover a transmetatarsal foot prosthesis and a hybrid partial foot prosthesis/ankle-foot orthosis provided by a prosthetist or an orthotist.
Providers must include sufficient information in the pre-approval application for PharmaCare to determine whether the prosthesis requested is an eligible benefit.
Insufficient Information | Sufficient Information |
---|---|
|
|
Note: A partial foot prosthesis that satisfies basic function does not include a silicone partial foot prosthesis fabricated by a manufacturer.
The maximum PharmaCare reimburses for components is calculated using the Girling Formula (PDF, 151KB). This formula is based on a percentage markup on the list cost of the item.
The Girling formula is used for items purchased outside of Canada. In these cases, the list price is adjusted to Canadian dollars and then the second column of the formula (imported item percentage markup) is used to include the additional cost of freight and duty to import the item into Canada.
Exchange rate on components purchased outside Canada
United States (US) exchange rates are reviewed regularly.
The rate used to set pricing is adjusted as needed based on significant fluctuations in the posted daily average US exchange rate, as published by the Bank of Canada.
The pricing rate is adjusted when the daily average rate changes more than five cents, for a period of five or more consecutive business days. When this occurs, the pricing rate is adjusted to reflect the rate posted on the first day of this period.
When the pricing rate is adjusted, it is published in the next PharmaCare Newsletter.
Maximum reimbursement amounts for definitive laminated sockets are defined in the Reimbursement Schedule for Definitive Sockets.
Maximum reimbursement amounts for labour costs for repairs/adjustments for various standard prosthetic procedures, excluding definitive sockets (noted above), are defined in the Reimbursement Schedule for Prosthetic and Orthotic Services and Supplies.
Maximum reimbursement amounts for osseointegration devices are defined in the Reimbursement Schedule for Osseointegration Components.
If no maximum reimbursement amount for a specific procedure is listed in the Reimbursement Schedule for Prosthetic Procedures, the procedure is subject to the hourly rate provided in the Reimbursement Schedule.
Reimbursement for all prosthetic services related to the manufacture and/or repair of a prosthetic limb is based on the provider’s usual and customary price up to PharmaCare maximum reimbursements specified in the Reimbursement Schedules.
PharmaCare coverage is limited to one check, test, or diagnostic socket, whether static or dynamic, per definitive socket.
Reimbursement depends on the client’s PharmaCare plan rules, including any annual deductible requirements.
All components submitted for PharmaCare approval (except loaner feet and knees) are to be purchased new from approved suppliers unless the patient’s own components can be reused. Warranty registration is required to enable warranty claims
Note: There is no coverage for individual office visits, or hospital visits/consultations.
An ocular prosthesis is an artificial eye, custom-made and fit by a certified ocularist1, that replaces an absent natural eye or fits over an injured, diseased, or underdeveloped eye. The prosthesis fits over an orbital implant or a shrunken non-functional eye, and under the eyelid.
1Ocularists must be certified by National Examining Board of Ocularists (NEBO).
PharmaCare covers ocular prostheses only for clients who:
PharmaCare does not cover:
Depending on the client’s circumstances, pre-approval for an ocular prosthesis may not be needed for PharmaCare coverage; see Section 5.3.2 below for more information.
To be reimbursed for dispensing an ocular prosthesis without pre-approval, the provider must ensure that
Note: Providers may make a note in the their own client file that they have confirmed an approved form or statement is on file with the P&O Clerk at HIBC. Once eligibility has been confirmed, providers are not required to contact the P&O Clerk again before they dispense subsequent prostheses or services without pre-approval.
The original prescription or a copy of it must be kept in the client’s file as proof the patient was eligible for coverage of an initial ocular prosthesis and/or related services.
A signed PharmaCare invoice must be retained in the client’s file as proof the patient received any device.
Any rationale for dispensing a replacement ocular prosthesis must be documented and kept in the client’s file.
The device provider may be liable for item/service costs if:
An application for coverage is required when:
Exceptional coverage will be considered on a case-by-case basis when an application for pre-approval is submitted by a device provider on behalf of the client. An appropriate rationale and all relevant documentation must be included in the application to explain why the client requires an ocular prosthesis at this time.
For pre-approved exceptional coverage, submit the HLTH 5404 - Prosthetic Benefits (Non-Limb) Application for Financial Assistance (PDF, 683KB). The application must follow the standard PharmaCare pre-approval process; see Section 7 of this manual for details. The application must provide enough information about the client’s exceptional circumstances to allow PharmaCare to make an informed decision. This must include, but is not limited to
A HLTH 5467 - PharmaCare Eligibility Awards and Settlements (PDF, 521KB) form is required alongside the initial application for coverage when a client’s need for the device arose from an injury, illness or other condition that was caused by an act or omission of another person.
PharmaCare coverage for ocular prostheses is limited to:
Actual reimbursement will depend on the client’s PharmaCare plan rules, including any annual deductible requirements.
The maximum reimbursement for ocular prostheses is detailed in the Non-Limb Prostheses PINs and Reimbursement Schedule.
Reimbursement for materials and labour related to the manufacture and/or repair of an ocular prosthesis is based on the provider’s usual and customary price, up to PharmaCare’s maximum reimbursement.
The maximum reimbursement for an ocular prosthesis includes all clinical labour costs and materials incurred in its creation and dispensing, including the following:
A provider warranty that all material and workmanship with respect to manufacture or repair of the device is free from defect for a period of 90 days from the time of dispensing.
An ear prosthesis is an artificial ear, custom-made and usually fit by an anaplastiologist, that replaces an absent natural ear.
A nose prosthesis is an artificial nose, custom-made and usually fit by an anaplastiologist, that replaces an absent natural nose.
PharmaCare covers custom-manufactured ear and nose prostheses only for clients who need a prosthesis to replace a missing ear and/or nose.
PharmaCare does not cover ear or nose prostheses used for the purpose of cosmetic enhancement.
Depending on the circumstances, pre-approval for a custom ear or nose prosthesis may not be needed for PharmaCare coverage; see Section 5.4.2 below for more information.
To be reimbursed for dispensing an ear or nose prosthesis without pre-approval, the provider must ensure that:
Note: Providers may make a note in the their own client file that they have confirmed that an approved form or statement is on file with the P&O Clerk at HIBC; once eligibility has been confirmed, providers are not required to contact the P&O Clerk again before they dispense subsequent prostheses or services without pre-approval.
The original prescription or a copy must be kept in the client’s file as proof the patient was eligible for coverage of an initial ear or nose prosthesis and/or related services.
A signed PharmaCare invoice must be retained in the client’s file as proof the patient received any device.
Any rationale for dispensing a replacement ear or nose prosthesis must be documented and kept in the client’s file.
The device provider may be liable for item/service costs if:
An application for coverage is required when:
Exceptional coverage will be considered on a case-by-case basis when an application for pre-approval is submitted by a device provider on behalf of the client. An appropriate rationale and all relevant documentation must be included in the application to explain why the client requires an ear or nose prosthesis at this time.
For pre-approved exceptional coverage, submit the HLTH 5404 - Prosthetic Benefits (Non-Limb) Application for Financial Assistance (PDF, 683KB). The application must follow the standard PharmaCare pre‑approval process; see Section 7 of this manual for details. The application must provide enough information about the client’s exceptional circumstances to allow PharmaCare to make an informed decision. This must include, but is not limited to:
A HLTH 5467 - PharmaCare Eligibility Awards and Settlements (PDF, 521KB) form is required alongside the initial application for coverage when a client’s need for the device arose from an injury, illness or other condition that was caused by an act or omission of another person.
PharmaCare coverage for an ear or nose prosthesis is limited to:
Actual reimbursement will depend on the client’s PharmaCare plan rules, including any annual deductible requirements.
The maximum reimbursement for ear and nose prostheses is detailed in the Non-Limb Prostheses PINs and Reimbursement Schedule.
Reimbursement for materials and labour related to the manufacture and/or repair of an ear or nose prosthesis is based on the provider’s usual and customary price, up to the PharmaCare maximum reimbursement.
The maximum reimbursement amount for an ear or nose prosthesis includes all clinical labour costs and materials incurred in its creation and dispensing, including the following:
A provider warranty that all material and workmanship with respect to manufacture or repair of the device is free from defect for a period of 90 days from the time of dispensing.
Subject to specific limits, PharmaCare covers breast prostheses and mastectomy supplies for eligible individuals who have undergone a mastectomy or lumpectomy, subject to the client’s PharmaCare plan rules including any deductible requirement.
PharmaCare does not cover breast prostheses required for
See the Mastectomy PINs and Reimbursement Schedule for details on maximum reimbursements.
For information on the replacement of a mastectomy device, see Section 6.1.
Pre-approval is not required for regular benefits.
When applying for pre-approval for exceptional coverage (e.g., a second prosthesis within the replacement period), the application must provide enough information about the exceptional circumstances to allow PharmaCare to make an informed decision.
The information must include, but not be limited to
Submit Applications for pre-approval on the HLTH 5404 - Prosthetic benefits: Non-Limb (PDF, 683KB) form.
PharmaCare covers the following eligible orthotic benefits:
Reimbursement is subject to the client’s PharmaCare plan rules, including any annual deductible requirement.
The term “initial devices and/or services” includes the first request for
PharmaCare does not cover
Ministry of Social Development and Poverty Reduction clients who are covered under PharmaCare Plan C may be able to obtain assistance through that Ministry for orthoses that PharmaCare does not cover (e.g., orthoses for adults; additional children’s orthoses, such as orthoses not manufactured at a PharmaCare provider’s premises, for upper extremities; foot orthoses, footwear).
Ministry of Children and Family Development (MCFD) clients who are covered under PharmaCare Plan F may be able to obtain assistance through that Ministry for orthoses that PharmaCare does not cover (e.g., orthopedic shoes; wrist and hand orthoses; cervical collars).
Maximum reimbursement for orthoses is based on the type or style of orthosis. The appropriate Product Identification Number (PIN) must be used on all applications and invoices.
Services related to the manufacture and or repair of an orthosis are based on the provider’s usual and customary price, up to PharmaCare’s maximum reimbursement as specified in the PINs and Reimbursement Schedule for Orthoses.
Reimbursement maximums for a basic orthosis include all clinical labour costs and materials incurred in its creation and dispensing, including the following:
A plagiocephaly helmet is a cranial remolding orthosis, custom-made and fitted by a certified orthotist for treatment of infants diagnosed with plagiocephaly, brachycephaly, and/or craniosynostosis.
PharmaCare covers plagiocephaly helmets only for clients who:
Depending on the circumstances, pre-approval for a helmet may not be needed for PharmaCare coverage (see Section 5.7.2 below for more information).
To be reimbursed for a plagiocephaly helmet without pre-approval, the provider must ensure that the:
Important: If the client is not registered for Fair PharmaCare, or covered by Plan C or Plan F before the helmet is dispensed, the family will be responsible for the full cost of the helmet. If a family does not know if they are covered by one of these plans, the P & O Clerk can confirm the client’s coverage status. If the client does not have the necessary PharmaCare coverage, the device provider can advise the family as to how to register for Fair PharmaCare or provide them with the Fair PharmaCare pamphlet (available in 15 languages) for details about registration.
If client has |
Client must |
---|---|
|
|
|
|
|
Note: a soft helmet for protection of the surgical site is not a PharmaCare benefit |
*As measured by a certified orthotist
How are cranial indices calculated?
Cranial index (CI) or cephalic ratio (CR) formula
Cranial vault asymmetry index (CVAI) formula
The orthotist must measure and record the necessary cranial index (CI) and/or cranial vault asymmetry index (CVAI) measurements on the HLTH 5450 - PharmaCare Orthotic Benefit—Plagiocephaly Helmet (PDF, 529KB) form.
The completed form, along with all required supporting documentation (e.g., referral from a plagiocephaly clinic, prescription from a pediatric neurosurgeon), must be kept in the client’s file as proof that the client was eligible for plagiocephaly helmet coverage.
The device provider may be liable for costs of the item/service and any associated costs, if the completed form is not
An application for coverage is required when a client does not meet the criteria outlined in Section 5.7.2.
Exceptional coverage will be considered on a case-by-case basis when a pediatric neurosurgeon or prescriber working at a plagiocephaly clinic requests exceptional coverage through a device provider. Submit applications for pre-approved exceptional coverage on the HLTH 5400 - Application for Financial Assistance: Orthotic Benefits (PDF, 716KB) form.
The application must follow the standard PharmaCare pre‑approval process; see Section 7 of this manual for details.
The application must provide enough information about the client’s exceptional circumstances to allow PharmaCare to make an informed decision. This must include, but is not limited to:
PharmaCare policy allows for a lifetime limit of one plagiocephaly helmet to treat positional plagiocephaly.
The maximum PharmaCare reimburses for a helmet is listed in the PINs and Reimbursement Schedule for Orthoses. Maximum reimbursement amounts include clinical labour and costs as specified in Section 5.6.3.
[Updated August 1, 2020]
A hip abduction orthosis is a brace, custom fitted by a certified orthotist, that keeps the patient’s knees bent in a flexed position and thighs spread apart (abducted). In infants, this posture facilitates normal growth and corrects the development of a hip joint.
Invoices for newborn babies who may not yet be registered under PharmaCare will need to be submitted manually to PharmaCare for payment to allow for the alignment of registration and eligibility. Failure to submit invoices for unregistered babies manually will result in the patient’s families having to pay the full cost.
PharmaCare covers hip abduction orthoses for infants aged 12 months or younger who
Parents of patients over 12 months old who are prescribed an abduction brace should submit an application to PharmaCare for consideration of exceptional coverage.
Depending on the circumstances, pre-approval for a hip abduction orthosis may not be needed for PharmaCare coverage; see Section 5.8.2 for more information.
Important: If the client is not registered for Fair PharmaCare or covered by Plan C or Plan F, the family will be responsible for the full cost of the brace. If a family does not know if they are covered by one of these plans, the P&O Clerk can confirm the client’s coverage status. If the client does not have the necessary PharmaCare coverage, the device provider can advise the family how to register for Fair PharmaCare or provide them with the PharmaCare pamphlet (available in 15 languages) about registration.
To be reimbursed for a hip abduction orthosis without pre-approval, the provider must ensure that the:
The original prescription or a copy must be kept in the client’s file as proof the patient was eligible for coverage of an initial hip abduction orthosis.
A signed PharmaCare invoice must be retained in the client’s file as proof the patient received any device.
Any rationale for dispensing a hip abduction orthosis must be documented and kept in the client file.
The device provider may be liable for item/service costs if:
An application for coverage is required when a client does not meet the criteria outlined in Section 5.8.1.
Exceptional coverage for a child over the age of 12 months will be considered on a case-by-case basis when an orthopedic specialist requests exceptional coverage through a device provider. Submit applications for pre-approved exceptional coverage on the HLTH 5400 - PharmaCare Orthotic Benefits for Financial Assistance (PDF, 716KB) form.
The application must follow the standard PharmaCare pre‑approval process; see Section 7 of this manual for details.
The application must provide enough information about the client’s exceptional circumstances to allow PharmaCare to make an informed decision. This must include, but is not limited to:
PharmaCare coverage for hip abduction orthoses is limited to one orthotic brace per lifetime of the client.
Actual reimbursement will depend on the client’s PharmaCare plan rules, including any annual deductible requirements.
The maximum reimbursement amount for a hip abduction orthosis includes all clinical labour costs and materials incurred in its creation and dispensing, including the following:
The maximum reimbursement for a hip abduction orthoses is detailed in the PINs and Reimbursement Schedule for Orthoses.
PharmaCare covers the following offloading benefits provided by an orthotist who is enrolled as a PharmaCare provider:
Actual reimbursement depends on a patient's PharmaCare plan rules, including Fair PharmaCare plan deductible. Refer to this list of PharmaCare Enrolled Orthotic Providers in British Columbia (PDF, 84KB).
The term “initial devices and/or services” includes the first claim for:
The term ‘’nearly healed” refers to a diabetic foot ulcer that has been assessed by a physician or nurse who has determined that their client will likely transition to an orthotic insert and therapeutic footwear in less than two weeks.
PharmaCare does not cover:
PharmaCare coverage for offloading orthotic devices and footwear is not available without pre-approval.
A copy or original referral must be kept in the client’s file as proof the patient was eligible for coverage of an offloading orthotic device and footwear.
A signed PharmaCare invoice must be retained in the client’s file as proof the patient received the device.
Any rationale for dispensing a replacement offloading orthotic device and footwear must be documented and kept in the client’s file.
The device provider may be liable for item/service costs if:
An application for coverage is required for all initial and renewal requests. Submit applications for pre-approved coverage on the HLTH 5418 - Application for Financial Assistance: Offloading Orthotic Benefits (PDF, 716KB) form.
Applications must follow the standard PharmaCare pre‑approval process; see Section 7 of this manual for details.
Ministry of Social Development and Poverty Reduction (SDPR) clients may be able to obtain assistance through SDPR’s Health Supplements Program for offloading devices that PharmaCare does not cover (e.g., air cast walking boot; orthotics and footwear needed to treat an acute diabetic foot ulcer; or orthotics and footwear needed to treat foot deformities).
The First Nations Health Authority (FNHA) covers wound care supplies, foot orthotics, and shoes for their clients under their Medical Supplies and Equipment benefit program.
PharmaCare coverage for an offloading orthotic insert and therapeutic footwear is limited to:
Actual reimbursement will depend on the client’s PharmaCare plan rules, including any annual deductible requirements.
The maximum reimbursement for offloading orthotic inserts and therapeutic footwear is detailed in the PINs and Reimbursement Schedule for Offloading Devices. The appropriate Product Identification Numbers (PINs) must be used on all claims and invoices.
Services related to the manufacture and/or repair of an orthosis are based on the provider’s usual and customary price, up to PharmaCare’s maximum reimbursement as specified in the PINs and Reimbursement Schedule for Offloading Devices.
Reimbursement maximums for basic offloading orthotic inserts, covers, and therapeutic footwear include all clinical labour costs and materials incurred in their creation and dispensing, including the following:
PharmaCare does not cover replacement of damaged, lost or stolen prostheses, orthoses or prosthetic supplies.
Note: Damaged, lost or stolen items may be covered by a client’s home or other insurance policy.
Providers should consider making adjustments or repairs if doing so could extend the useful life of a device (i.e., delaying the need to replace the device).
Note: PharmaCare will not approve, or provide coverage for, both an adjustment or repair and a new prosthesis.
The P&O Program covers adjustments and repairs to prostheses and orthoses only when
PharmaCare does not reimburse the repair or adjustment costs on upgraded components or devices that exceed the basic function approved by PharmaCare. For example, PharmaCare does not cover repair or maintenance costs if a traditional socket amputee has obtained a micro-processor knee instead of a basic function knee.
Providers may claim either
Adjustments may include the costs of the measurable materials and labour required to maintain or improve the fit of a device (e.g., stretching an orthosis for growth, shrinking a socket for atrophy etc.). Items such as leather, Dacron, pads, carbon cloth and others should be detailed with the amount (i.e., ½ metre) and the price being charged. Items such as teaspoons of glue and short lengths of Velcro should not be listed as they are considered shop supplies and are not a PharmaCare benefit.
1Providers are required to warrant that all material and workmanship with respect to the manufacture or repair of the device be free from defect for a period of 90 days from time of completion. PharmaCare does not cover adjustments or repairs during this period that are not the result of significant physiological change, as they should be covered by the provider’s 90-day in-house warranty.
The application for pre-approval must provide enough information to allow PharmaCare to make an informed decision. It must include:
Applications for pre-approval must be submitted on the appropriate form:
Adequate documentation to support claims for repairs and adjustments must be kept on file, available for audit. This includes, but is not limited to:
Prosthetic devices (excluding mastectomy prostheses) may be replaced
The three-year minimum limit may be waived if it is clearly demonstrated, in writing, that the client’s changing health or other circumstances require replacement of the socket to maintain its performance of basic function according to the client’s current basic ADL.
Potential rationales may include
Note: In the event of significant physiological change, the prosthetist, or orthotist in the case of a transmetatarsal prosthesis, may submit an application that includes team assessments, physician recommendations, and/or other written documentation, to demonstrate the client’s need for a new socket. However, even during the first year, every effort should be taken to limit a client to one definitive socket. All best practices should be used before the fitting of the laminated, definitive socket, such as pre-fitting edema control (shrinkers) and dynamic diagnostic sockets.
A mastectomy device may not be replaced for at least 24 months from the previous approval, and then only upon demonstration that the existing device no longer meets the client’s needs (e.g., basic activities of daily living (ADL)). Refer to PINs and Reimbursement Schedule for Mastectomy Supplies.
If a client switches providers for any reason, they are subject to the same PharmaCare coverage rules governing replacements and are entitled to only one prosthesis every three years.
PharmaCare will consider a new application, with appropriate justification, for portions of a device recommended by a new provider, but clients should be aware that most components must be reused. For example, PharmaCare may consider the provision of a new socket, if it is warranted, but the new prosthetist, or orthotist in the case of a transmetatarsal prosthesis, will be required to reuse all the other components of the previous device.
When a replacement device is requested due to physiological change, providers should ensure that they provide adequate information for PharmaCare to make a decision.
Insufficient information | Sufficient information |
---|---|
|
Details about your client, including but not limited to the following:
|
When a replacement device is requested due to wear and tear, providers should ensure that they provide adequate information for PharmaCare to make a decision.
Insufficient information | Sufficient information |
---|---|
|
Description of which parts are worn out and the nature of the wear or damages such as
|
The following quantities are covered subject to the time limits specified:
Item | Quantity/Time |
---|---|
shrinkers | six per year |
liners | two per year |
sealing suspension sleeves | two every four months |
neoprene suspension sleeves | four every four months |
silo sheaths | four every four months |
prosthetic gloves | two vinyl gloves per year OR one silicone glove per year |
socks, cotton socks and stump socks |
no more than:
|
Orthoses may be replaced:
Exception: Replacement of an orthosis before the time limit may be approved if it is clearly demonstrated, in writing, that the client’s changing health or other circumstances require replacement of the orthosis to maintain its performance of basic function according to the client’s current basic ADL. Team assessments, recommendations from a physician or an authorized BC Children’s Hospital nurse practitioner working in an orthopedic clinic, and/or written documentation may be submitted to demonstrate this requirement. Refer to Section 5.1.4 for information regarding Teams.
When a replacement device is requested due to growth or physiological change, providers should ensure that they provide adequate information for PharmaCare to make a decision.
Insufficient Information | Sufficient Information |
---|---|
|
Details about your request, including but not limited to the following:
|
When a replacement device is requested due to wear and tear, providers should ensure that they provide adequate information for PharmaCare to make a decision.
Insufficient information | Sufficient information |
---|---|
|
Details about your request, including but not limited to the following:
|
If a client switches providers for any reason, they are subject to the same PharmaCare coverage rules governing replacements, and are entitled to only one orthosis per year, and then only if the orthotist demonstrates the device no longer meets the client’s needs (e.g., basic activities of daily living (ADL)).
PharmaCare will consider a new application, with appropriate justification, for a device recommended by a new provider, but clients should be aware that the device may not be approved.
Offloading orthotic inserts may be replaced:
Therapeutic footwear may be replaced:
Orthotic covers may be replaced:
Exception: replacement of an insert or footwear before the time limit may be approved if it is clearly demonstrated, in writing, that the client’s changing health or other circumstances require replacement of the device(s) to maintain an appropriate post-treatment plan. Team assessments, recommendations made by physician and nurses specializing in wound care, and/or written documentation may be submitted to demonstrate this requirement. See Section 5.1.4 for information regarding teams.
Note: Indicate on the form if the application is on behalf of a client who is a resident of a licensed long-term care facility (Plan B). For information on PharmaCare Plans, refer to Section 7, PharmaCare Policy Manual.
Health Insurance BC – PharmaCare
Attn: P&O Clerk
PO Box 9655 Stn Prov Govt
Victoria BC V8W 9P2
Important: Please make sure that the information is complete, accurate and legible. Providers are required to submit applications using PharmaCare pricing. Incomplete, inaccurate and/or illegible applications will be returned. Providers will have to revise and resubmit the appropriate part of the form or provide additional information, as requested.
Reminder: Changing adjudication result is not allowed
Backdating of claims on PharmaNet is permitted only for the purpose of correcting a previously adjudicated claim, not to alter adjudication results. Also, claims must be made at the time of dispense, and cannot be held and entered at a later date to get a better adjudication result.
All pre-approval application forms require the following:
Specific instructions for these sections follow below.
Note: Some applications will require additional information, as applicable.
Client information
A prescription from a physician is required for all new and upgraded prosthetic and orthotic devices. A prescription from an authorized nurse practitioner (NP) working in an orthopedic clinic at BC Children’s Hospital is accepted for new and upgraded pediatric orthotic devices. Subsequent applications for coverage of prosthetic and orthotic replacement devices that do not involve a medical change may be referred by any BC NP for the purpose of submitting a claim to PharmaNet.
Detailed Rationale for Request section
Your application for pre-approval must provide enough information to allow PharmaCare to make an informed decision. It must include, but is not limited to:
Insufficient information | Sufficient Information |
---|---|
Simple re-statement of client's:
Stating what the client did in the past, without identifying when or what the client is able to do now. |
Details about the client's:
Information from all other sources (e.g., medical reports, physician/BCCH orthopedic clinic NP statements, physiotherapy notes, etc.). For a sample of an initial prosthesis rationale, see box below. |
Rationales for all work should provide justification for the request based on the client’s health, needs, and expected outcomes. Some examples of specific rationales include
An example of a good rationale for a new amputee’s first limb prosthesis:
More complex cases may require a prescription from a specialist physician.
Note: Providers may attach a work order to an application if it gives sufficient detail about the work to be done and the rationale for the device. If a work order is not attached, providers must complete Schedule ‘C’ along with a detailed rationale for the device.
Details of Request
Applications must include the appropriate PIN. When replacing a significant component such as a foot, knee or hand/hook, use the appropriate PIN for that level of amputation, not the PINs for supplies.
Providers may request approval for no more than two separate PINs on each application, all appropriate details for each device must be included.
The following ancillary documents provide PINs for use on pre-approval and invoice forms. Where abbreviations are allowed, they are noted in these documents.
Enter the PIN for the entire benefit. PINs can be found in the Reimbursement Schedules.
Benefit PINs refer to the type of device or service (e.g., trans-tibial prosthesis, ankle-foot orthosis), not specific components.
If providing several items on one device, use the PIN that accounts for the majority of the cost (e.g., when replacing a foot on a trans-tibial prosthesis, adding a new cosmesis and making an adjustment, code all the costs to the trans-tibial PIN; when adding in pads for $240 and making adjustments for $120, use the repair PIN)
Pharmacare Eligibility Personal Injury
Only the client or the client’s agent (if the client is a minor or not capable of signing on their own) should complete this section of the form. If the client requires an agent, have the agent note the legal relationship between the agent and the client on the form, next to the agent’s signature.
Completion of this section certifies the client is not adequately covered by other funding sources, including court awards or settlements for damages (the client must answer a significant number of questions regarding possible sources of other funding. If the client has received, or will receive, other funding, they must fill in HLTH 5467 - PharmaCare Eligibility Personal Injury (PDF, 521KB)
Client Certification section
Only the client should sign this section of the form, unless the client is a minor or not capable of signing on their own. If the client requires an agent, have the agent note the legal relationship between the agent and the client on the form, next to the agent’s signature. For children in care, or foster children, the social worker must sign for the care.
Never ask the client to sign a blank form and leave it at the site for future use. The information in the Client Certification section may change and the client is required to confirm that they have read and understood the rest of the form. PharmaCare may delay or deny payments to providers who request that clients sign blank forms.
The client’s signature certifies that the client
Provider Certification section
This signature certifies that the prosthetist/orthotist/health care provider
If an OPC resident is participating in the development of the item/service to be provided, the resident must have a supervisor on site.
PharmaCare Use Only section
This section will be completed by PharmaCare and will contain the decision from PharmaCare when it is returned to you. Please see Understanding PharmaCare’s decision for more details.
Form 5402
Schedule A
Schedule A (Past Medical History) is to be completed by the client or the provider (based on client/practitioner input). It is important to check all boxes that apply. Completion of Schedule A and a prescription must accompany all initial and upgraded requests (e.g., clients who have had revision surgery).
Schedule B
Schedule B (Upper Extremity Amputee) is to be completed and submitted by the provider for each upper extremity application. Must include information on who will be providing training on the electro/myo-electro device and what training they have had to qualify them as the trainer. Must include information on who will be providing the functional training for the arm and what training they have had to qualify them as the trainer.
Schedule C
Schedule C (Detailed Information) is to be completed to outline the components requested for the client. Providers must include PharmaCare pricing and totals on this schedule. Providers may include their work order instead of Schedule C but it must include the same basic information in the same format (i.e. PharmaCare pricing and detailed part #) as on Schedule C.
If clients will be receiving an upgraded component and paying the extra cost, the basic PharmaCare coverage amounts should be shown in the PharmaCare Price column, and the upgraded pricing and details should be shown in the Provider Price column. For example:
Component | Quality/Part #/Details | PharmaCare Price | Provider Price |
---|---|---|---|
Socket insert/liners |
2 Alpha Locking ALL-5066e 6mm* *ALC-5066e is the part number for the cushion style. |
$1,040.00 | $1,119.00 |
1 Iceross Seal-in X5 I-3663XX |
Pre-approval is valid for six months from the date that the approved application form is returned to the health care provider. The expiry date is indicated in the Approval Ends field of the returned application form.
All work must be completed—and all items delivered to the client—by the Approval Ends date specified on the returned application. If all work is not completed and dispensed before that date, the approval expires and a new approval must be requested.
Requests for a new approval must include in the rationale:
There is no guarantee that the new request will be approved.
Sometimes a provider needs to resubmit an application to address questions from the P&O Committee or the client’s changing health needs. To expedite the resubmission and reduce the number of pages being faxed, please:
This process may be repeated if the response does not address the issues or brings up new issues.
Exceptions to PharmaCare pre-approval requirements for a limited number of items may be granted only when all the following conditions are true:
In these exceptional cases, PharmaCare waiving the need for pre-approval does not guarantee that PharmaCare will approve the requested device or services. For example, if a client’s injury and subsequent amputation were due to a car crash, the client’s vehicle insurance would cover the necessary prosthesis. Additionally, items or services are not approved if they exceed basic function according to the client’s basic ADL.
The following limited benefits, when dispensed during active hospital treatment or in a time-sensitive rehabilitation situation, do not always require pre-approval before they are dispensed, but do require approval before a claim can be made:
Note: Replacements for these supplies (after active treatment) require pre-approval, if the cost for replacement is $400 or more.
In these exceptional cases, complete and submit the appropriate application as soon as possible following the procedure in Section 7.1 (i.e., after the device has been dispensed to the client, in the case of an IPOP, before providing the device to the patient, in the case of shrinkers or a diagnostic socket).
If the client is receiving, or is wait-listed for, procedures for the management of spasticity or increased tone, indicate this on the HLTH 5400 - Application for Pre-Approval for the Orthosis Benefits (PDF, 617KB).
If any such procedure is planned, indicate whether the procedure is medical or surgical.
Occasionally clients may request components or devices that exceed basic function.
As PharmaCare will only approve and reimburse for basic function components, providers should follow the procedures below for submitting an application.
PharmaCare will only approve basic function components that would meet the patient’s needs if they were not upgrading.
Clients, third-party insurance, or other funding agencies are responsible for all costs above those required to provide basic function.
Inform the client that PharmaCare cannot determine, in advance, the portion of the claim it will pay, because reimbursement depends on the client’s deductible status at the time the claim is adjudicated. If the application is approved, the returned application will state the maximum amount that could be paid by PharmaCare. Clients are advised to check their current Fair PharmaCare deductible/co-payment levels by phoning HIBC before making the decision to purchase an upgraded device that exceeds basic function.
Inform the client that PharmaCare does not cover repair or adjustment costs for components that exceed the basic function specified by PharmaCare. For example, PharmaCare will not cover the maintenance and/or repair costs when the client has obtained a microprocessor knee instead of a basic function knee.
If the client agrees to assume the additional costs (including any future repair or adjustment costs), apply for the component/device/service that meets the basic function criteria and put the cost of that device in the PharmaCare Price column. Add a second line with the details of the upgraded device and put the price of that device in the Provider Price column. If all basic function criteria are met, the provider will receive approval for the cost of the device/service in the PharmaCare Price column that meets the client’s needs (i.e., basic activities of daily living (ADL)).
Note in the client file that an enhanced device/service was provided, and PharmaCare was billed for the basic device/service as approved.
The following items do not require pre-approval before being dispensed and claimed:
Cost-splitting to avoid pre-approval requirements is strictly prohibited. All items, components, supplies, and services related to a given prosthetic or orthotic device must be included on a single application for pre-approval.
If a provider finds that additional components are necessary for a device after the application for pre-approval has been submitted, the provider must submit a new application for pre-approval that includes the additional components before the device is created and dispensed.
After the application for pre-approval has been submitted, if a provider finds that not all requested components/services are necessary for a device, the provider may submit a claim for a lesser amount for the device that was created and dispensed. The provider does not have to submit a new application form. However, if submitting a manual claim, they should identify on the invoice what was not provided and why.
If a provider is not able to complete all requested components/services for an approved work order (e.g., patient deceased; patient moved to new provider) after the application for pre-approval has been submitted, the provider may submit a new application for pre-approval that includes all the components/services provided that cannot be sent back or used by a different client. The provider requires pre-approval of the items dispensed before a claim can be made. (See section 7.9).
When pre-approval is not required (see Section 2.4.2), providers must keep adequate documentation on file. The client notes, invoices, and supporting documents should provide, but not be limited to:
Note: The pricing, components and services must meet PharmaCare’s basic function and maximum fee guidelines, and are only applicable for eligible PharmaCare benefits.
The documentation must provide enough detail to meet PharmaCare audit requirements, but it can be done in point form.
The PharmaCare P&O Committee reviews all applications, taking into consideration
PharmaCare sends the provider an annotated copy of the application form stating if coverage has been approved. The approval includes:
Providers will not be reimbursed for any items/services dispensed before they receive PharmaCare approval.
This area is completed by the P&O Committee members and/or HIBC staff.
Providers must read this section carefully, as it contains the reimbursement amount, the client’s current plan and relevant dates.
Request Approved/More Information Required/Request Not Approved
In this section PharmaCare indicates whether or not an application has been approved, if more information is required, or if a request has been denied.
If the application is approved, the maximum PharmaCare reimbursement is recorded (“Approved Amount”). This is the maximum PharmaCare could pay. The actual amount PharmaCare reimburses depends on the client’s PharmaCare plan rules and deductibles at the time of dispense.
If more information is required, PharmaCare identifies the specific additional information or documentation needed in the “Comments” field. The provider must gather the required information and resubmit the application for further consideration. See Section 7.3 for more information.
If an application is denied, PharmaCare returns the application form indicating “Request Not Approved”. The explanation of why approval was not granted is noted in the “Comments” field.
PharmaCare Plan
The approved application form states the plan under which the client was covered at the time PharmaCare received the application (“PharmaCare Plan”). If a client’s plan has changed by the time of dispense, the out-of-pocket costs may also change. For instance, if the client has switched from a plan that offers 100% coverage to a plan that has a family deductible and co-payment, PharmaCare may cover
Clients are responsible for any outstanding balance not covered by their PharmaCare plan. To ensure the client’s PharmaCare plan information is still correct, verify the information with the client before the device is dispensed to them.
Note: To be eligible for income-based coverage, clients must be registered for Fair PharmaCare before the item is dispensed. Retroactive coverage cannot be provided.
If the Plan on the approved application form is identified as N/R or N/Reg, it means the client is not registered for Fair PharmaCare. The client must register for Fair PharmaCare before receiving the device or service in order to receive the maximum income-based PharmaCare assistance to which they can be entitled. If the client does not register, they will have a $10,000 deductible, and will be responsible for the first $10,000 of the claim.
Approval Ends
When pre-approval is granted, PharmaCare enters a financial control into PharmaNet to allow a claim to be submitted and processed. This control expires six months after PharmaCare returns the approved form to the provider (“Approval Ends”), or on the date that the first claim for that PIN is entered.
If the device is not ready before this date, or if the service is not provided before this date, the provider must apply using a new pre-approval application (see Section 7.2).
For Plan B (Long-term Care), Plan C (B.C. Income Assistance) or Plan F (Children in the At Home Program) clients, PharmaCare reimburses the full cost claimed, up to the PharmaCare-approved maximum amount for that device or service.
For Fair PharmaCare (Plan I) clients, the amount1 that PharmaCare actually reimburses may be less than the PharmaCare approved maximum amount.
1PharmaCare cannot determine the portion of the claim it will pay for Fair PharmaCare clients in advance because reimbursement depends on the client’s deductible status at the time the claim is adjudicated. For this reason, the amount on the approved form specifies the maximum amount that could be paid by PharmaCare.
All providers:
PharmaCare does not reimburse providers for products or services that are dispensed before the application form is approved and faxed back to the provider.
Devices/services must be dispensed within six months of the date on the approved application form (see the “Approval Ends” field on the form).
If devices/services cannot be dispensed within the six month period, a new application must be submitted to PharmaCare for pre-approval (see Section 7.2).
Claims for devices that do not require pre-approval must be submitted on the date of dispense (see “Submitting claims“ below). Ensure all required PharmaCare Invoice forms and other documents are completed and signed at the time of dispense.
A PharmaCare Invoice form acts as a record of the products/services dispensed and of the client’s acceptance of the dispense and its terms and conditions.
All providers, both manual and online, must complete all relevant fields on the appropriate PharmaCare Invoice on or before the date of dispense.
On the date of dispense, all providers must have the client (or the client’s agent) sign and date the invoice in the Client Certification section.
Providers who fail to obtain the client’s signature on the date of dispense, or ask the client to sign a blank invoice may not be eligible for payments.
If the item required pre-approval, providers must ensure that the quantities and PIN(s) on the invoice correspond to those on the approved application form.
All providers must keep a signed copy of the PharmaCare invoice in the client file for PharmaCare review.
Actual reimbursement is calculated as follows: Actual reimbursement = (maximum approved reimbursement) - (client’s deductible and co-pay at the time the claim is adjudicated)
When a client dies after pre-approval has been given and before the final device is provided, PharmaCare may provide partial reimbursement for the actual work that has been completed.
Providers should complete and submit a new pre-approval application form itemizing the custom work completed prior to the client’s death, and the parts and components that cannot be returned or reused elsewhere. Include details about what is being requested, and why, in the rationale of the new pre-approval application. Submit the application for pre-approval through the normal process.
Once PharmaCare gives pre-approval for the new request, the provider should complete the invoice using a dispense date prior to the date the client died. Submit the invoice to the PharmaCare Help Desk for special processing.
Prosthetic or orthotic benefits claims must be submitted to PharmaCare only after all the work/service is complete, and the device, if any, has been dispensed to the client (i.e., not the day the work is completed, or the day that the approval is received).
Online claims must be submitted to PharmaNet at the time of dispense.
Do not batch online claims and submit weekly.
The “dispense date” must be on or before the “Approval Ends” date stated on the approved application form. PharmaNet will not process claims for a service date beyond the approval ends period.
Because manual claims must be recorded in PharmaNet by March 31 of the year following the date the item was dispensed, manual invoices must be submitted to HIBC early to allow time for staff to process the claim and enter it into PharmaNet before the March 31 deadline.
For details about online claims submission, please see Section 3, PharmaCare Policy Manual. For details on completion of PharmaCare invoices, please see section 7.9.2 above.
If you receive a “client not entitled” response:
Check the claim to ensure that you have submitted the correct:
If the device/service required PharmaCare pre-approval, make sure you have:
Important: If the “Approval Ends” date has passed, you will need to (a) complete a new application requesting pre-approval and (b) indicate, in the rationale, the reason why the work was not completed within the six months.
If you have confirmed the above information is correct and the claim is still not accepted, contact the P&O Clerk at HIBC for assistance (see Section 8.2).
Hip Abduction Orthoses
Invoices for newborn babies who may not yet be registered under their parent’s PharmaCare plan will need to be submitted manually to PharmaCare for payment to allow for the alignment of registration and eligibility. Failure to submit invoices for unregistered babies manually will result in the patient’s families having to pay the full cost.
Invoices for infants who are already registered with PharmaCare can be processed as normal.
Residents in Plan B facilities
Submit all claims for residents of Plan B long-term care facilities as follows:
Documentation Requirements
Documentation requirements apply to claims submitted by both providers and clients.
A Fair PharmaCare client may submit a manual claim for a prosthetic or orthotic device/service directly to PharmaCare only if they have paid the health care provider the entire cost of the device or service. Otherwise the provider should submit the invoice and collect only the balance from the client, once PharmaCare has paid its portion of the total cost.
Manual claims for Fair PharmaCare, Plan B (Long-term Care), Plan C (B.C. Income Assistance) and Plan F (Children in the At Home Program) must include either:
OR
If a provider chooses to have the client pay the full amount of the items/services and apply directly to PharmaCare for reimbursement, the provider remains responsible for:
Note: Providers are encouraged to fax clients’ claims to HIBC, even when payment is due to the client, not the provider.
Submission procedures
Fax invoices and supporting documents to the HIBC PharmaNet Help Desk at 250-405‑3587
OR
Mail the documents to:
PharmaNet Help Desk
Health Insurance BC
P.O. Box 9655 Stn Prov Govt
Victoria, BC V8W 9P2
Note: The Pharmaceutical Services Act and the Provider Regulation allow for the Ministry of Health to take actions against providers who make inappropriate claims. These actions can include, but are not limited to, the recovery of the funds, the imposition of limits and conditions, or cancellation of the provider’s enrolment in the PharmaCare program.
All provider claims—both manual and online—are processed on PharmaNet. Once client eligibility has been confirmed, PharmaNet adjudicates the claim to determine the portion, if any, of the claim that PharmaCare will reimburse. Fair PharmaCare clients must meet their family deductible before PharmaCare issues any reimbursement.
The Ministry of Finance issues payments for accepted claims to the provider each week.
If the PharmaCare portion of a Fair PharmaCare manual claim is $0.00 because the client has not met their deductible, PharmaCare will send the provider a zero-payment letter. In this case, the provider will need to obtain payment from the client or the client’s private insurer.
Whenever a zero-payment letter is sent to the provider, the provider should advise the client to submit the paid receipt to PharmaCare, so the benefit amount can be added to their claims record and be counted toward their Fair PharmaCare deductible.
To receive payment by direct deposit, complete a BC Government Direct Deposit Application. Submit the application and an original void cheque to:
Information Support
Health Insurance BC
P.O. Box 9655 Stn Prov Govt
Victoria, BC V8W 9P2
A Direct Deposit Application was included in the PharmaCare welcome package you received after enrolling. If you change your banking information, you can find additional copies of the FIN 312 - Direct Deposit Application (PDF, 304KB) form online
Note: For more information on completing this form, refer to the Payments to Providers — Section 8.12, PharmaCare Policy Manual.
PharmaCare may reject a claim for any of the following reasons:
If PharmaCare rejects a claim, the claim form is returned with an explanation of why the invoice was not processed.
PharmaCare does not return forms for accepted claims.
PharmaCare returns all incomplete or incorrect claims to the submitter (provider or client) for further details, correction or completion.
If an incomplete or incorrect invoice form is returned to you:
The maximum amount paid will be the PharmaCare approved amount.
PharmaCare does not pay for devices that were not included in an original application, or for costs due to changes made to the original application, even if the change is for under $400.
If a change to an application is required, you must resubmit a pre-approval application, containing the updated rationale, and details of all original and new devices/services.
All PharmaCare claims are subject to audit to confirm their compliance with the terms of the PharmaCare Provider Enrolment Agreement and with PharmaCare policies and procedures.
For details on PharmaCare Audit policy and procedures, see the Section 10, PharmaCare Policy Manual.
The PharmaNet Help Desk is available to providers 24 hours a day, 7 days a week, including all statutory holidays except Christmas day.
When calling the Help Desk, please be prepared to provide your Site ID.
Phone the PharmaNet Help Desk to:
Note: The Help Desk cannot provide information about a client’s Fair PharmaCare deductible, family maximum, or co-payment to a provider; only clients can obtain that information.
Dial the PharmaNet Help Desk:
Note: Provider-only telephone numbers should not be given out to the public.
To enquire about the status of a client’s application, telephone the P&O Clerk.
The P&O Clerk is the provider’s point of contact for the P&O Program and application forms. A clerk is available from 8:30 am to 4:30 pm Monday to Friday.
Contact the P&O Clerk to:
Contact the P&O Clerk:
The PharmaCare website contains all the application forms, manuals, and information sheets that device providers require, including:
Clients can contact us for: